Boston Scientific reported net sales of $2.22 billion in its third quarter fiscal year 2017 results.
Here's what you should know:
1. Boston Scientific's sales increased 5.6 percent year-over-year on a reported basis. .
2. Boston Scientific reported adjusted earnings of $283 million or $0.20 per share.
3. Boston Scientific CEO Mike Mahoney said in a release, "Our global team is delivering strong performance as we continue to invest in a deep and innovative portfolio and expand into faster-growing markets."
4. Boston Scientific's endoscopy division increased its sales by $7 million year-over-year.
5. Concerning rest-of-year outlooks, Boston Scientific expects earnings between $8.98 billion and $9.01 billion or a growth of up to 8 percent.